Agilent Technologies, Inc. - Diagnostics and Genomics ClearSeq Comprehensive Cancer, 96 auto,
The Agilent ClearSeq Comprehensive Cancer, 96 reactions, automated (Part Number: 5190-8013) is a targeted next-generation sequencing (NGS) panel designed for comprehensive cancer research. This product enables the detection of genetic variants across a broad range of cancer-related genes, supporting high-throughput analysis with automation compatibility. The kit is optimized for use with Agilent's SureSelect target enrichment system, providing reliable and reproducible results for variant detection in cancer samples. It is suitable for laboratories seeking efficient, large-scale cancer genomics workflows.